Skip to main content
. 2018 Dec 11;17(2):2283–2295. doi: 10.3892/ol.2018.9821

Table IV.

Results of differential screening.

mRNA lncRNA


Comparison Total, n Upregulated, n Downregulated, n Total, n Upregulated, n Downregulated, n
C vs. N 3,070 1,836 1,234 2,209 1,299 910
C vs. Y 1,315 933 382 922 493 429
Y vs. N 2,712 1,213 1,499 2,250 1,241 1,009

lncRNA, long non-coding RNA; N, normal gastric tissue samples; Y, primary gastrointestinal stromal tumor samples; C, imatinib mesylate-resistant gastrointestinal stromal tumor samples.